Infinity Pharmaceuticals Inc (INFI)

Add to Watchlists
Create an Alert
1.48 +0.02  +1.37% NASDAQ May 22, 13:01 Delayed 2m USD
View Full Chart
INFI Price Chart
View All Key Stats

INFI Key Stats

View All INFI News

INFI News

View All Events

INFI Events

Date Type Description
08/07/2019 16:30 EDT Misc Infinity Pharmaceuticals Inc Second Quarter Earnings Conference Call in 2019
08/07/2019 Earnings Infinity Pharmaceuticals Inc Second Quarter Earnings in 2019 Release
05/07/2019 16:30 EDT Misc Infinity Pharmaceuticals Inc First Quarter Earnings Conference Call in 2019
05/07/2019 Earnings Infinity Pharmaceuticals Inc First Quarter Earnings in 2019 Release
03/14/2019 08:00 EDT Misc Infinity Pharmaceuticals Inc Fourth Quarter Earnings Conference Call in 2018
03/14/2019 Earnings Infinity Pharmaceuticals Inc Fourth Quarter Earnings in 2018 Release
03/14/2019 Misc Infinity Pharmaceuticals Inc Annual Report in 2018
11/05/2018 16:30 EST Misc Infinity Pharmaceuticals Inc Third Quarter Earnings Conference Call in 2018
11/05/2018 Earnings Infinity Pharmaceuticals Inc Third Quarter Earnings in 2018 Release
08/07/2018 16:30 EDT Misc Infinity Pharmaceuticals Inc Second Quarter Earnings Conference Call in 2018
View All Performance Charts

INFI Total Returns Comparison

INFI Fundamentals

Income Statement View Statement

Revenue (TTM) 118.54M
Total Expenses (TTM) 40.48M
Net Income (TTM) -15.55M

Balance Sheet View Statement

Total Assets (Quarterly) 74.74M
Total Liabilities (Quarterly) 35.34M
Shareholders Equity (Quarterly) 39.40M

Cash Flow Statement View Statement

Cash from Operations (TTM) -11.13M
Cash from Investing (TTM) -0.294M
Cash from Financing (TTM) 33.80M

INFI Ratings

Advertisement

INFI One Page Reports

INFI Analyst Coverage

Consensus Recommendations
Buy Recommendations Upgrade
Outperform Recommendations Upgrade
Hold Recommendations Upgrade
Underperform Recommendations Upgrade
Sell Recommendations Upgrade
Consensus Recommendation Upgrade
Consensus Rating Upgrade
Target Price
Price 1.48
Price Target Upgrade
Price Target Upside (Daily) Upgrade
Edit

Profile

  • URL: http://www.infi.com
  • Investor Relations URL: http://phx.corporate-ir.net/phoenix.zhtml?c=121941&p=irol-irhome
  • HQ State/Province: Massachusetts
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Growth
  • Next Earnings Release: Aug. 07, 2019
  • Last Earnings Release: May. 07, 2019
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: Infinity Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing novel medicines for the treatment of specific cancers. The company's developed products and those under development include therapies targeting hematologic malignancies, or blood cancers; refractory indolent non-Hodgkin lymphoma; refractory chronic lymphocytic leukemia; and solid tumors, including melanoma and non-small cell lung cancer. Infinity has a strategic partnership with AbbVie to develop some of its oncology-related treatments.

INFI Comparables

Edit
VSTM Verastem Oncology
LGND Ligand Pharmaceuticals Inc
SRPT Sarepta Therapeutics Inc
AMGN Amgen Inc
BMY Bristol-Myers Squibb Co

Excel Add-In Codes

  • Name: =YCI("INFI","name")
  • Description: =YCI("INFI","description")
  • Sector: =YCI("INFI","sector")
  • Industry: =YCI("INFI","industry")
  • Est. Current Fiscal Year End: =YCI("INFI","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Other INFI Resources

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.